{
    "clinical_study": {
        "@rank": "3018", 
        "arm_group": [
            {
                "arm_group_label": "Treatment as Usual", 
                "arm_group_type": "No Intervention", 
                "description": "Those in the Treatment as Usual group will not receive the brief intervention for substance use but will receive a brief health education brochure."
            }, 
            {
                "arm_group_label": "Brief Intervention", 
                "arm_group_type": "Experimental", 
                "description": "Those in the Brief Intervention group will receive a brief motivational intervention aimed at encouraging the participant to decrease their substance use."
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators goal is to pilot a substance use-related brief intervention (BI) for youth\n      with chronic medical conditions, obtaining preliminary evidence of feasibility,\n      acceptability and impacts of the approach for reducing substance use among this group."
        }, 
        "brief_title": "Reducing Problematic Substance Use in Youth With Chronic Medical Conditions", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Alcohol Abuse", 
            "Drug Abuse"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Substance-Related Disorders", 
                "Alcoholism"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  14-18 years old\n\n          -  Currently being treated for diabetes, rheumatologic disorders, asthma, or ulcerative\n             colitis (UC) at Boston Children's Hospital with a duration of chronic illness of at\n             least one year\n\n          -  Previous participation in the screening validation study\n\n          -  Evidence of problems related to substance use\n\n        Exclusion Criteria:\n\n          -  Medically or emotionally unstable or otherwise unable to provide assent/consent\n\n          -  Unable to speak/read English\n\n          -  Unable to use a computer keyboard and/or complete an interviewer-assisted\n             questionnaire"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "14 Years"
        }, 
        "enrollment": {
            "#text": "52", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01709201", 
            "org_study_id": "FP01009751"
        }, 
        "intervention": {
            "arm_group_label": "Brief Intervention", 
            "description": "Those in the intervention arm will undergo a 10-minute discussion with a trained interventionist aimed at encouraging decreased substance use.", 
            "intervention_name": "Brief Intervention", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Alcohol abuse", 
            "Drug abuse", 
            "Diabetes Mellitus", 
            "Persistent Asthma", 
            "Juvenile Arthritis", 
            "Ulcerative Colitis"
        ], 
        "lastchanged_date": "January 2, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02115"
                }, 
                "name": "Boston Children's Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Reducing Problematic Substance Use in Youth With Chronic Medical Conditions", 
        "other_outcome": [
            {
                "description": "We will compare the percent days abstinent from substances between the Treatment as Usual and Intervention groups 90 days post baseline", 
                "measure": "Percent Days Abstinent 90 days post baseline", 
                "safety_issue": "No", 
                "time_frame": "90 days post baseline"
            }, 
            {
                "description": "We will evaluate the incidents of disease complications between the Treatment as Usual and Intervention groups 30 days post baseline", 
                "measure": "Medical complications 90 days post baseline", 
                "safety_issue": "No", 
                "time_frame": "90 days post baseline"
            }
        ], 
        "overall_contact": {
            "email": "sharon.levy@childrens.harvard.edu", 
            "last_name": "Sharon Levy, MD", 
            "phone": "617-355-5433"
        }, 
        "overall_contact_backup": {
            "email": "shari.vanhook@childrens.harvard.edu", 
            "last_name": "Shari Van Hook, MPH", 
            "phone": "617-355-5433"
        }, 
        "overall_official": [
            {
                "affiliation": "Children's Hospital Boston", 
                "last_name": "Sharon Levy, MD, MPH", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Children's Hospital Boston", 
                "last_name": "Elissa Weitzman, ScD, MSc", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "We will compare the percent days abstinent from substances between the Treatment as Usual and Intervention groups 30 days post baseline", 
            "measure": "Percent days abstinent", 
            "safety_issue": "No", 
            "time_frame": "30 days post baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01709201"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "We will evaluate the incidents of disease complications between the Treatment as Usual and Intervention groups 30 days post baseline", 
            "measure": "Medical complications", 
            "safety_issue": "No", 
            "time_frame": "30 days post baseline"
        }, 
        "source": "Children's Hospital Boston", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Children's Hospital Boston", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}